A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons
A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons
复制标题
DOI:
10.1038/sj.emboj.7600441
复制
发表时间:
2005-01-12
期刊:
影响因子:
11.4
通讯作者:
Pant, HC
中科院分区:
文献类型:
--
作者:
Zheng, YL;Kesavapany, S;Pant, HC
The extracellular aggregation of amyloid beta (Abeta) peptides and the intracellular hyperphosphorylation of tau at specific epitopes are pathological hallmarks of neurodegenerative diseases such as Alzheimer's disease ( AD). Cdk5 phosphorylates tau at AD- specific phospho- epitopes when it associates with p25. p25 is a truncated activator, which is produced from the physiological Cdk5 activator p35 upon exposure to Abeta peptides. We show that neuronal infections with Cdk5 inhibitory peptide ( CIP) selectively inhibit p25/ Cdk5 activity and suppress the aberrant tau phosphorylation in cortical neurons. Furthermore, Abeta(1-42)- induced apoptosis of these cortical neurons was also reduced by coinfection with CIP. Of particular importance is our finding that CIP did not inhibit endogenous or transfected p35/ Cdk5 activity, nor did it inhibit the other cyclin- dependent kinases such as Cdc2, Cdk2, Cdk4 and Cdk6. These results, therefore, provide a strategy to address, and possibly ameliorate, the pathology of neurodegenerative diseases that may be a consequence of aberrant p25 activation of Cdk5, without affecting ' normal' Cdk5 activity.